Table 4.
Analysis of patients (n = 82) vs. controls (n = 82) FokI polymorphism genotypes and alleles frequencies for T2DM patients and healthy controls.
| FokI Polymorphism | T2DM Patients n (%) |
Healthy Controls n (%) |
Odds Ratio (OR) | 95% CI | p-Value |
|---|---|---|---|---|---|
| Genotypes | |||||
| CC | 44 (53.7) | 49 (59.8) | CC vs. (CT and TT) 0.78 | 0.42–1.45 | 0.4 |
| CT | 31 (37.8) | 27 (32.9) | CT vs. (CC and TT) 1.24 | 0.65–2.35 | 0.5 |
| TT | 7 (8.5) | 6 (7.3) | TT vs. (CC and CT) 1.18 | 0.38–3.68 | 0.7 |
| Alleles | |||||
| C | 119 (72.6) | 125 (76.2) | 0.82 | 0.50–1.36 | 0.4 |
| T | 45 (27.4) | 39 (23.8) | 1.21 | 0.74–1.99 |
A logistic regression model was used. p-value is significant at ≤0.05.